Bain Capital Life Sciences Investors, LLC Q2 2019 Filing

Filed August 14, 2019

Portfolio Value

$196.9B

Holdings

5

Report Date

Q2 2019

Filing Type

13F-HR

All Holdings (5 positions)

#StockSharesValue% PortfolioType
1
—DICERNA PHARMACEUTICALS INC
7,330,237$115.5B58.64%
2
REPLREPLIMUNE GROUP INC
2,838,968$41.6B21.14%
3
—MARINUS PHARMACEUTICALS INC
5,042,735$20.9B10.63%
4
SLDBSOLID BIOSCIENCES INC
1,989,444$11.4B5.81%
5
—APTINYX INC
2,225,092$7.4B3.78%